Announcements Trials
Browse Landscape

Phase

Phase NA 135Phase 1 16Phase 2 14Phase 1/2 6Phase 4 3Phase EARLY_PHASE1 2Phase 3 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Epidural Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 26pembrolizumab 17Radiotherapy 17Specimen Handling 16Nivolumab 15Cyclophosphamide 14Temozolomide 11Biopsy 11fludarabine 9Fluorodeoxyglucose F18 9X-Rays 8Etoposide 7Bevacizumab 7Standard of Care 6Radiation 6Paclitaxel 6Dexamethasone 6Cisplatin 6Carboplatin 6Surgical Procedures, Operative 5Ipilimumab 5Doxorubicin 5Aspirin 5venetoclax 4fluciclovine F-18 4atezolizumab 4abemaciclib 4Vincristine 4Rituximab 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Blood Specimen Collection × 1 year × Clear all
NCT05204290 2026-03-24

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
1 enrolled

Neoplasms, Epidural Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

Poitiers University Hospital

Phase EARLY_PHASE1 Recruiting
220 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡